Mark Lawlor

Mark Lawlor has a diverse and extensive work experience in the pharmaceutical industry. Mark currently serves as the Vice President, Product Development at Pharmaron, where they lead the establishment of the Product Development team and business in Hoddesdon, UK. Mark is responsible for developing the commercialization strategy, P&L accountability, organization leadership and development, and identifying new clients and collaborations.

Prior to their current role, Mark worked at Thermo Fisher Scientific as the Senior Director, Drug Product Development from 2014 to 2021. In this position, they led the Milton Park site in the UK, which focused on contract development and GMP manufacture of oral solid drug products. Mark achieved significant growth and profitability for the site, expanded the workforce, and established a strong business reputation through on-time project delivery, cost management, and client relationships.

Before Thermo Fisher Scientific, Mark held various roles at Patheon from 2001 to 2014. Mark served as the Director, PDS Bourgoin, where they established and led the PDS business unit, exceeding growth targets and gaining FDA approvals. Mark also worked as the Associate Director, PDS EU Business Management, leading the Global Project Management Office for Pharmaceutical Development Services. Additionally, Mark was involved in the design and implementation of a new PDS facility and the commercialization of small annual volume products.

Mark's early career includes positions at Procter & Gamble, where they worked as a Scientist and later became a Product Development Manager.

Overall, Mark Lawlor's work experience showcases their expertise in product development, team leadership, business growth, and regulatory compliance in the pharmaceutical industry.

Mark Lawlor received their education as follows:

- From 1991 to 1995, they attended University College Dublin, where they earned a PhD in Pharmacology.

- Prior to their doctoral studies, Mark Lawlor obtained a Bachelor of Science (BSc) in Pharmacology from University College Dublin, which they completed between 1987 and 1991.

- Mark'searlier education includes attending Templeogue College from 1982 to 1987, although the degree and field of study are not specified.